Does prostate cancer family history have an impact on active surveillance adherence in men with low- or favourable intermediate risk disease?

被引：0
|
作者：
Leni, R. [1 ]
Stabile, A. [1 ]
Gandaglia, G. [1 ]
Mazzone, E. [1 ]
Cucchiara, V [1 ]
Bandini, M. [1 ]
Pellegrino, A. [1 ]
De Angelis, M. [1 ]
Quarta, L. [1 ]
Zaurito, P. [1 ]
Robesti, D. [1 ]
Fossati, N. [2 ]
Brembilla, G. [3 ]
Zaffuto, E. [4 ]
Deho, F. [4 ]
De Cobelli, F. [3 ]
Montorsi, F. [1 ]
Briganti, A. [1 ]
机构：
[1] Univ Vita Salute San Raffaele, Dept Urol, IRCCS Osped San Raffaele, Milan, Italy
[2] Univ Svizzera Italiana, Dept Urol, Ente Osped Cantonale, Lugano, Switzerland
[3] Univ Vita Salute San Raffaele, Dept Radiol, IRCCS Osped San Raffaele, Milan, Italy
[4] Osped Circolo & Macchi Fdn, Dept Urol, Varese, Italy
来源：
EUROPEAN UROLOGY | 2023年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0953
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer
    Kato, Takuma
    Tohi, Yoichiro
    Honda, Tomoko
    Matsuda, Iori
    Osaki, Yu
    Naito, Hirohito
    Matsuoka, Yuki
    Okazoe, Homare
    Taoka, Rikiya
    Tsunemori, Hiroyuki
    Ueda, Nobufumi
    Sugimoto, Mikio
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (03) : 289 - 297
  • [22] Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active Surveillance
    Nyame, Yaw A.
    Almassi, Nima
    Haywood, Samuel C.
    Greene, Daniel J.
    Ganesan, Vishnu
    Dai, Charles
    Zabell, Joseph
    Reichard, Chad
    Arora, Hans
    Zampini, Anna
    Crane, Alice
    Hettel, Daniel
    Elshafei, Ahmed
    Fareed, Khaled
    Stein, Robert J.
    Berglund, Ryan K.
    Gong, Michael
    Jones, J. Stephen
    Klein, Eric A.
    Stephenson, Andrew J.
    JOURNAL OF UROLOGY, 2017, 198 (03): : 591 - 598
  • [23] Active Surveillance for Intermediate Risk Prostate Cancer
    Laurence Klotz
    Current Urology Reports, 2017, 18
  • [24] Active Surveillance for Intermediate Risk Prostate Cancer
    Klotz, Laurence
    CURRENT UROLOGY REPORTS, 2017, 18 (10)
  • [25] ACTIVE SURVEILLANCE IN INTERMEDIATE RISK PROSTATE CANCER
    Chandrasekar, Thenappan
    Herrera-Caceres, Jaime O.
    Klotz, Laurence
    ARCHIVOS ESPANOLES DE UROLOGIA, 2019, 72 (02): : 157 - 166
  • [26] Are men with favorable intermediate-risk prostate cancer candidates for active surveillance?
    Raldow, Ann Caroline
    Zhang, Danjie
    Chen, Ming-Hui
    Braccioforte, Michelle H.
    Moran, Brian Joseph
    D'Amico, Anthony Victor
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [27] Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance
    Davis, John W.
    Ward, John F., III
    Pettaway, Curtis A.
    Wang, Xuemei
    Kuban, Deborah
    Frank, Steven J.
    Lee, Andrew K.
    Pisters, Louis L.
    Matin, Surena F.
    Shah, Jay B.
    Karam, Jose A.
    Chapin, Brian F.
    Papadopoulos, John N.
    Achim, Mary
    Hoffman, Karen E.
    Pugh, Thomas J.
    Choi, Seungtaek
    Troncoso, Patricia
    Logothetis, Christopher J.
    Kim, Jeri
    BJU INTERNATIONAL, 2016, 118 (01) : 68 - 76
  • [28] Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers
    Henk van der Poel
    Laurence Klotz
    Gerald Andriole
    Abdel-Rahmène Azzouzi
    Anders Bjartell
    Olivier Cussenot
    Freddy Hamdy
    Markus Graefen
    Paolo Palma
    Arturo Rodriguez Rivera
    Christian G. Stief
    World Journal of Urology, 2015, 33 : 907 - 916
  • [29] Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers
    van der Poel, Henk
    Klotz, Laurence
    Andriole, Gerald
    Azzouzi, Abdel-Rahmene
    Bjartell, Anders
    Cussenot, Olivier
    Hamdy, Freddy
    Graefen, Markus
    Palma, Paolo
    Rodriguez Rivera, Arturo
    Stief, Christian G.
    WORLD JOURNAL OF UROLOGY, 2015, 33 (07) : 907 - 916
  • [30] PROSTATE CANCER Time for active surveillance of intermediate-risk disease?
    Ahmed, Hashim U.
    NATURE REVIEWS UROLOGY, 2013, 10 (01) : 6 - 8
12345